IL-4 inhibits expression of the formyl peptide receptor gene in mouse peritoneal macrophages

Journal of Interferon and Cytokine Research

Volumn 25, Issue 1, 2005, Pages 11-19

  Dai, Yalei ^a   Major, Jennifer ^a   Novotny, Michael ^a   Hamilton, Thomas A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CHEMOTACTIC PEPTIDE; FORMYLPEPTIDE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; STAT6 PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; INFLAMMATION; LEUKOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RNA STABILITY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 12144274834     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.11     Document Type: Article

References (43)

1. ROSSI, D., and ZLOTNIK, A. (2000). The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242.
2. BAGGIOLINI, M. (2001). Chemokines in pathology and medicine. J. Intern. Med. 250, 91-104.
3. KUBES, P., and WARD, P.A. (2000). Leukocyte recruitment and the acute inflammatory response. Brain Pathol. 10, 127-135.
4. LEY, K. (1996). Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc. Res. 32, 733-742.
5. LE, Y., MURPHY, P., and WANG, J. (2002). Formyl-peptide receptors revisited. Trends Immunol. 23, 541-548.
6. MURPHY, P.M. (1994). The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593-633.
7. LOCATI, M., RIBOLDI, E., OTERO, K., MARTINEZ, F., RIVA, F., PERRIER, P., BAVIERA, S., SIGNORELLI, P., BONECCHI, R., ALLAVENA, P., SOZZANI, S., and MANTOVANI, A. (2001). Regulation of the chemokine system at the level of chemokine receptor expression and signaling activity. Immunobiology 204, 536-542.
8. OLSON, T., and LEY, K. (2002). Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R7-28.
9. NELMS, K., KEEGAN, A.D., ZAMORANO, J., RYAN, J.J., and PAUL, W.E. (1999). The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701-738.
10. HAMILTON, T.A., OHMORI, Y., and TEBO, J. (2002). Regulation of chemokine expression by anti-inflammatory cytokines. Immunol. Res. 25, 229-245.
11. GOERDT, S., and ORFANOS, C.E. (1999). Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142.
12. OHMORI, Y., and HAMILTON, T.A. (2000). Interleukin-4/STAT6 represses STAT1 and NF-kappa B-dependent transcription through distinct mechanisms. J. Biol. Chem. 275, 38095-38103.
13. OHMORI, Y., and HAMILTON, T.A. (1998). STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J. Biol. Chem. 273, 29202-29209.
14. GOENKA, S., YOUN, J., DZUREK, L.M., SCHINDLER, U., YULEE, L.Y., and BOOTHBY, M. (1999). Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation. J. Immunol. 163, 4663-4672.
15. MAJOR, J., FLETCHER, J.E., and HAMILTON, T.A. (2002). IL-4 pretreatment selectively enhances cytokine and chemokine production in lipopolysaccharide- stimulated mouse peritoneal macrophages. J. Immunol. 168, 2456-2463.
16. GAO, J.L., and MURPHY, P.M. (1993). Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 268, 25395-25401,
17. CHIRGWIN, J.M., PRYZBYLA, R.J., MACDONALD, R.J., and RUTTER, W.J. (1979). Isolation of biologically active RNA from sources enriched in ribonuclease. Biochemistry 18, 5295-5299.
18. OHMORI, Y., STRASSMAN, G., and HAMILTON, T.A. (1990). cAMP differentially regulates expression of mRNA encoding IL-1a and IL-1b in murine peritoneal macrophages. J. Immunol. 10, 3333-3339.
19. OBIRI, N.I., LELAND, P., MURATA, T., DEBINSKI, W., and PURI, R.K. (1997). The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol. 158, 756-764.
20. RYAN, J.J., McREYNOLDS, L.J., KEEGAN, A., WANG, L.H., GARFEIN, E., ROTHMAN, P., NELMS, K., and PAUL, W.E. (1996). Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4, 123-132.
21. OHMORI, Y., SMITH, M.F., Jr., and HAMILTON, T.A. (1996). IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J. Immunol. 157, 2058-2065.
22. LEVINGS, M.K., and SCHRADER, J.W. (1999). IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms. J. Immunol. 162, 5224-5229.
23. SCHRODER, A.J., PAVLIDIS, P., ARIMURA, A., CAPECE, D., and ROTHMAN, P.B. (2002). Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J. Immunol. 168, 996-1000.
24. IRIBARREN, P., CUI, Y.H., LE, Y., YING, G., ZHANG, X., GONG, W., and WANG, J.M. (2003). IL-4 down-regulates lipopolysaccharide-induced formyl peptide receptor 2 in murine microglial cells by inhibiting the activation of mitogen-activated protein kinases. J. Immunol. 171, 5482-5488.
25. THIVIERGE, M., PARENT, J.-L., STANKOVA, J., and ROLAPLESZCZYNSKI, M. (1999). Modulation of formyl peptide receptor expression by IL-10 in human monocytes and neutrophils. J. Immunol. 162, 3590-3595.
26. WAHL, S.M. (1999). TGF-beta in the evolution and resolution of inflammatory and immune processes. Intro. Microbes Infect, 1, 1247-1249.
27. WAHL, S.M. (1992). Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J. Clin. Immunol. 12, 61-74.
28. CUI, Y.-H., LE, Y., GONG, W., PROOST, P., VAN DAMME, J., MURPHY, W.J., and WANG, J.M. (2002). Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J. Immunol. 168, 434-442.
29. KRACHT, M., and SAKLATVALA, J. (2002). Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 20, 91-106.
30. HOLLOWAY, A.F., RAO, S., and SHANNON, M.F. (2002). Regulation of cytokine gene transcription in the immune system. Mol. Immunol. 38, 567-580.
31. TSURUTA, L., ARAI, N., and ARAI, K. (1998). Transcriptional control of cytokine genes. Int. Rev. Immunol. 16, 581-616.
32. OHH, M., and TAKEI, F. (1995). Regulation of ICAM-1 mRNA stability by cycloheximide: role of serine/threonine phosphorylation and protein synthesis. J. Cell. Biochem. 59, 202-213.
33. ROSS, J. (1997). A hypothesis to explain why translation inhibitors stabilize mRNAs in mammalian cells: mRNA stability and mitosis. Bioessays 19, 527-529.
34. KIM, H.S., ARMSTRONG, D., HAMILTON, T.A., and TEBO, J.M. (1998). IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J. Leukocyte Biol. 64, 33-39.
35. GORDON, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
36. HARIBABU, B., RICHARDSON, R., VERGHESE, M., BARR, A., ZHELEV, D., and SNYDERMAN, R. (2000). Function and regulation of chemoattractant receptors. Immunol. Res. 22, 271-279.
37. GUHANIYOGI, J., and BREWER, G. (2001). Regulation of mRNA stability in mammalian cells. Gene 265, 11-23.
38. WILUSZ, C.J., WORMINGTON, M., and PELTZ, S.W. (2001). The cap-to-tail guide to mRNA turnover. Nat. Rev. Mol. Cell. Biol. 2, 237-246.
39. XU, L., RAHIMPOUR, R., RAN, L., KONG, C., BIRAGYN, A., ANDREWS, J., DEVRIES, M., WANG, J.M., and KELVIN, D.J. (1997). Regulation of CCR2 chemokine receptor mRNA stability. J. Leukocyte Biol. 62, 653-660.
40. SICA, A., SACCANI, A., BORSATTI, A., POWER, C.A., WELLS, T.N., LUINI, W., POLENTARUTTI, N., SOZZANI, S., and MANTOVANI, A. (1997). Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185, 969-974.
41. PENTON-ROL, G., POLENTARUTTI, N., LUINI, W., BORSATTI, A., MANCINELLI, R., SICA, A., SOZZANI, S., and MANTOVANI, A. (1998). Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. J. Immunol. 160, 3869-3873.
42. SACCANI, A., SACCANI, S., ORLANDO, S., SIRONI, M., BERNASCONI, S., GHEZZI, P., MANTOVANI, A., and SICA, A. (2000). Redox regulation of chemokine receptor expression. Proc. Natl. Acad. Sci. USA 97, 2761-2766.
43. VASUDEVAN, S., and PELTZ, S. (2003). Nuclear mRNA surveillance. Curr. Opin. Cell. Biol. 15, 332-337.